OA-225 Optimising second line anchor drug options for children with HIV in Africa: 96 week results of the CHAPAS-4 randomised trial
Lugemwa, Abbas, Szubert, Alexander J, Ndebele, Wedu, Walker, Sarah, Turkova, Anna, Tafeni, Sue, Siziba, Grace, Shakeshaft, Clare, Nduna, Bwendo, Nazzinda, Rashida, Nambi, Esether, Mwamabazi, Mwate, Musoro, Godfrey, Musiime, Victor, Mulenga, Veronica, Mujuru, Hilda, McIlleron, Helen, Makumbi, Shafic, Lungu, Joyce, Kityo, Cissy, Dudakia, Nimisha, Doerholt, Katja, Chabala, Chishala, Bwakura-Dangarembizi, Mutsa, Bamford, Alasdair, Gibb, Diana M
Published in BMJ global health (17.12.2023)
Published in BMJ global health (17.12.2023)
Get full text
Journal Article